Review of Doravirine Resistance Patterns Identified in Participants During Clinical Development-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Review of Doravirine Resistance Patterns Identified in Participants During Clinical Development

Published:2020-09-09 Issue:5 Volume:85 Page:635-642
ISSN:1525-4135
Container-title:JAIDS Journal of Acquired Immune Deficiency Syndromes
language:en
Short-container-title:

Author:

Martin Elizabeth Anne,Lai Ming-Tain,Ngo Winnie,Feng Meizhen,Graham Donald,Hazuda Daria J.,Kumar Sushma,Hwang Carey,Sklar Peter,Asante-Appiah Ernest

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Infectious Diseases

Reference19 articles.

1. Nonnucleoside reverse transcriptase inhibitor resistance and the role of the second-generation agents;Adams;Ann Pharmacother.,2010

2. In vitro characterization of MK-1439, a novel HIV-1 nonnucleoside reverse transcriptase inhibitor;Lai;Antimicrob Agents Chemother.,2014

3. Rational design of doravirine: from bench to patients;Hwang;ACS Infect Dis.,2020

4. Pharmaceutical, clinical, and resistance information on doravirine, a novel non-nucleoside reverse transcriptase inhibitor for the treatment of HIV-1 infection;Pham;Drugs Context.,2020

5. Doravirine suppresses common nonnucleoside reverse transcriptase inhibitor-associated mutants at clinically relevant concentrations;Feng;Antimicrob Agents Chemother.,2016

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive database of HIV mutations selected during antiretroviral in vitro passage experiments;Antiviral Research;2024-10

2. Switching Human Immunodeficiency Virus Therapy;Infectious Disease Clinics of North America;2024-09

3. HIV-1 transmitted drug resistance in newly diagnosed individuals in Italy over the period 2015–21;Journal of Antimicrobial Chemotherapy;2024-07-19

4. Challenges for Novel Antiretroviral Development in an Era of Widespread tenofovir-disoproxil/lamivudine (or emtricitabine)/dolutegravir availability (TLD) Availability;Clinical Infectious Diseases;2024-07-11

5. Switch to fixed-dose doravirine (100 mg) with islatravir (0·75 mg) once daily in virologically suppressed adults with HIV-1 on antiretroviral therapy: 48-week results of a phase 3, randomised, open-label, non-inferiority trial;The Lancet HIV;2024-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3